CA2050677A1 - Methode de mesure visuelle de la glycemie - Google Patents

Methode de mesure visuelle de la glycemie

Info

Publication number
CA2050677A1
CA2050677A1 CA 2050677 CA2050677A CA2050677A1 CA 2050677 A1 CA2050677 A1 CA 2050677A1 CA 2050677 CA2050677 CA 2050677 CA 2050677 A CA2050677 A CA 2050677A CA 2050677 A1 CA2050677 A1 CA 2050677A1
Authority
CA
Canada
Prior art keywords
test
separation
whole blood
visual
test strip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2050677
Other languages
English (en)
Other versions
CA2050677C (fr
Inventor
Ernest J. Kiser
Edward G. Rice
Michael F. Tomasco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
Ernest J. Kiser
Edward G. Rice
Michael F. Tomasco
Lifescan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ernest J. Kiser, Edward G. Rice, Michael F. Tomasco, Lifescan filed Critical Ernest J. Kiser
Publication of CA2050677A1 publication Critical patent/CA2050677A1/fr
Application granted granted Critical
Publication of CA2050677C publication Critical patent/CA2050677C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • G01N33/523Single-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
CA 2050677 1990-09-06 1991-09-04 Methode de mesure visuelle de la glycemie Expired - Lifetime CA2050677C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57836490A 1990-09-06 1990-09-06
US578,364 1990-09-06

Publications (2)

Publication Number Publication Date
CA2050677A1 true CA2050677A1 (fr) 1992-03-07
CA2050677C CA2050677C (fr) 2003-04-08

Family

ID=24312551

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2050677 Expired - Lifetime CA2050677C (fr) 1990-09-06 1991-09-04 Methode de mesure visuelle de la glycemie

Country Status (1)

Country Link
CA (1) CA2050677C (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797817A1 (fr) 2005-12-19 2007-06-20 F.Hoffmann-La Roche Ag Capteur de type sandwich pour la détermination de la concentration des analytes
WO2007071562A1 (fr) 2005-12-19 2007-06-28 F. Hoffmann La-Roche Ag Capteur en sandwich destine a determiner une concentration d'analyte
EP2302376A1 (fr) 2006-08-08 2011-03-30 F. Hoffmann-La Roche AG Capteur électrochimique destiné à la détermination d'une concentration analytique
US8172866B2 (en) 2006-09-04 2012-05-08 Roche Diagnostics Operations, Inc. Medical aid
US8409382B2 (en) 2009-03-13 2013-04-02 Roche Diagnostics Operations, Inc. Method for producing an analytical consumable
US8439834B2 (en) 2005-12-02 2013-05-14 Roche Diagnostics Operations, Inc. Analysis system with user-friendly display element
US8618511B2 (en) 2007-09-19 2013-12-31 Roche Diagnostics Operations, Inc. Marking method for the reject marking of test elements
WO2017045992A1 (fr) * 2015-09-17 2017-03-23 Robert Bosch Gmbh Dispositif commandé par chimie sèche pour l'analyse d'un échantillon de matériel biologique

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1987761B1 (fr) 2007-05-03 2019-10-23 F. Hoffmann-La Roche AG Capteur tubulaire destiné à la détection d'un analyte
WO2009032760A2 (fr) 2007-08-30 2009-03-12 Pepex Biomedical Llc Capteur électrochimique et procédé de fabrication
WO2009051901A2 (fr) 2007-08-30 2009-04-23 Pepex Biomedical, Llc Capteur électrochimique et procédé de fabrication
US11224367B2 (en) 2012-12-03 2022-01-18 Pepex Biomedical, Inc. Sensor module and method of using a sensor module
US11045124B2 (en) 2014-06-04 2021-06-29 Pepex Biomedical, Inc. Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8439834B2 (en) 2005-12-02 2013-05-14 Roche Diagnostics Operations, Inc. Analysis system with user-friendly display element
EP1797817A1 (fr) 2005-12-19 2007-06-20 F.Hoffmann-La Roche Ag Capteur de type sandwich pour la détermination de la concentration des analytes
WO2007071562A1 (fr) 2005-12-19 2007-06-28 F. Hoffmann La-Roche Ag Capteur en sandwich destine a determiner une concentration d'analyte
EP2302376A1 (fr) 2006-08-08 2011-03-30 F. Hoffmann-La Roche AG Capteur électrochimique destiné à la détermination d'une concentration analytique
EP3282250A1 (fr) 2006-08-08 2018-02-14 Roche Diabetes Care GmbH Capteur électrochimique destiné à la détermination d'une concentration analytique
US10060877B2 (en) 2006-08-08 2018-08-28 Roche Diabetes Care, Inc. Electrochemical sensor for determining an analyte concentration
US8172866B2 (en) 2006-09-04 2012-05-08 Roche Diagnostics Operations, Inc. Medical aid
US8618511B2 (en) 2007-09-19 2013-12-31 Roche Diagnostics Operations, Inc. Marking method for the reject marking of test elements
US10535442B2 (en) 2007-09-19 2020-01-14 Roche Diabetes Care, Inc. Marking method for the reject marking of test elements
US8409382B2 (en) 2009-03-13 2013-04-02 Roche Diagnostics Operations, Inc. Method for producing an analytical consumable
US8899290B2 (en) 2009-03-13 2014-12-02 Roche Diagnostics Operations, Inc. Method for producing an analytical consumable
WO2017045992A1 (fr) * 2015-09-17 2017-03-23 Robert Bosch Gmbh Dispositif commandé par chimie sèche pour l'analyse d'un échantillon de matériel biologique

Also Published As

Publication number Publication date
CA2050677C (fr) 2003-04-08

Similar Documents

Publication Publication Date Title
CA1248434A (fr) Dispositif et methode pour la separation et l'analyse du sang entier
CA2133407C (fr) Filtre a separation des cellules sanguins et mode d'emploi
US3933594A (en) Method and device for determining the concentration of a substance in a fluid
US3552925A (en) Whole blood separation method and test using same
EP0654659B1 (fr) Dispositif d'épreuve de volume déterminé
EP0441325B1 (fr) Essai de cholestérol non instrumenté
GR1000779B (el) Τεχνικες διαχωρισμου αιματος και ανιχνευσεως αναλυτη.
GB2321967A (en) Opaque reaction matrix for the analysis of whole blood
CA2050677A1 (fr) Methode de mesure visuelle de la glycemie
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
IL94087A0 (en) Methods,reagents and test kits for determining the presence or quantitiy of biological components in an analyzed sample
GB2322699A (en) Methods and devices for determination of an analyte in body fluid
WO2002006828A3 (fr) Detecteur d'hemoglobine
CA2075193A1 (fr) Appareil d'essai de specimens
CN1394281A (zh) 用于分析物测定的试剂测试条带
MX9705534A (es) Portador de prueba diagnostica con campo de pruebas de capas multiples y metodo en el cual se usa para determinar un analito o substancia que se va a analizar.
DE69817794D1 (de) Verfahren zur bestimmung des prozentualen anteils von glykosiliertem hämoglobin
DE69416828T2 (de) Vorrichtung zur chromatographischen bestimmung, die einander entgegenstellbare teile enthalten
CA2297965A1 (fr) Cartouche d'analyse
CA2024206A1 (fr) Dispositif et methode pour le dosage des fructosamines
US5264180A (en) Mobile reagents in an analyte assay in a self-contained apparatus
EP0926484A3 (fr) Papier d'essai et tête de recueil d'analyte
US5919419A (en) Analyzer cuvette, method and diagnostic test kit for determination of analytes in whole blood samples
AU583737B2 (en) Process and reagent for the specific determination of fructosamine
EP0316919A3 (en) Vaginal sample test and reagents

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry